# A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children

> **NCT00468819** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 140 (actual)

## Conditions studied

- Magnetic Resonance Imaging

## Interventions

- **DRUG:** Gadobutrol (Gadavist, Gadovist, BAY86-4875)

## Key facts

- **NCT ID:** NCT00468819
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00468819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00468819, "A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00468819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*